AnaptysBio, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 42.21 million compared to USD 26.41 million a year ago. Basic loss per share from continuing operations was USD 1.59 compared to USD 0.93 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.47 USD | -2.00% | -1.84% | +9.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.57% | 641M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.57% | 22.48B | |
-9.51% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023